AYTU
Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aytu BioPharma Inc. revenue for the quarter ending March 31, 2026 was 12.4 M, a 32.74% decrease year-over-year.
- Aytu BioPharma Inc. revenue for the twelve months ending March 31, 2026 was 59.9 M, a 8.62% decrease year-over-year.
- Aytu BioPharma Inc. annual revenue for 2025 was 66.4 M, a 1.84% increase from 2024.
- Aytu BioPharma Inc. annual revenue for 2024 was 65.2 M, a 39.31% decrease from 2023.
- Aytu BioPharma Inc. annual revenue for 2023 was 107.4 M, a 11.10% increase from 2022.
- Aytu BioPharma Inc. annual revenue for 2022 was 96.7 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aytu BioPharma Inc. Earnings — FAQ
Aytu BioPharma Inc. (AYTU) earnings over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AYTU's earnings history?
The chart and table above show Aytu BioPharma Inc.'s earnings by year and by quarter, including the growth rate.